Geron GERN Gross product revenue — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Geron in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Geron's gross product revenue — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Geron's gross product revenue — total revenues?
- Geron (GERN) reported gross product revenue — total revenues of $65.35M in Q1 2026.
- How has Geron's gross product revenue — total revenues changed year-over-year?
- Geron's gross product revenue — total revenues increased by 44.2% year-over-year, from $45.31M to $65.35M.
- What does gross product revenue — total revenues mean?
- This metric represents the total gross revenue generated from the sale of pharmaceutical products before accounting for deductions such as rebates, discounts, returns, and allowances. It serves as a primary indicator of the underlying market demand and commercial adoption of the company's therapeutic offerings. By isolating gross figures, investors can assess the total top-line value created by product sales prior to the impact of contractual pricing adjustments.